Successful treatment of COVID-associated fungal infection due to Scopulariopsis and Aspergillus in a girl with acute lymphoblastic leukemia

Pediatr Blood Cancer. 2023 May;70(5):e30218. doi: 10.1002/pbc.30218. Epub 2023 Feb 12.

Authors

Shih-Hsiang Chen¹, Tsung-Yen Chang¹, Chen-Yen Kuo², Chih-Chen Chang³, Tang-Her Jaing¹, Chih-Jung Chen², Yhu-Chering Huang², Cheng-Hsun Chiu²

Affiliations

¹ Division of Pediatric Hematology-Oncology, Chang Gung Memorial Hospital, Chang Gung University, College of Medicine, Taoyuan, Taiwan.
² Division of Pediatric Infectious Diseases, Chang Gung Memorial Hospital, Chang Gung University, College of Medicine, Taoyuan, Taiwan.
³ Department of Medical Imaging and Intervention, Chang Gung Memorial Hospital, Chang Gung University, College of Medicine, Taoyuan, Taiwan.

PMID: 36775920
DOI: 10.1002/pbc.30218

No abstract available

Publication types

Letter

MeSH terms

Antifungal Agents / therapeutic use
Aspergillus
COVID-19* / complications
Female
Humans
Mycoses* / drug therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma* / complications
Precursor Cell Lymphoblastic Leukemia-Lymphoma* / drug therapy
Scopulariopsis*

Substances

Antifungal Agents